Skip to main content
ONO PHARMACEUTICAL CO., LTD. logo

ONO PHARMACEUTICAL CO., LTD. — Investor Relations & Filings

Ticker · 4528 ISIN · JP3197600004 LEI · 529900G26L4NG4GFJZ86 T Manufacturing
Filings indexed 65 across all filing types
Latest filing 2020-08-06 Interim / Quarterly Rep…
Country JP Japan
Listing T 4528

About ONO PHARMACEUTICAL CO., LTD.

https://www.ono-pharma.com/en

Ono Pharmaceutical Co., Ltd. is a research and development-oriented pharmaceutical company dedicated to discovering and developing innovative medicines. With a history spanning over 300 years since its founding in 1717, the company focuses on addressing unmet medical needs for patients worldwide. Its primary research and development areas are oncology, immunology, and neurology. Ono Pharmaceutical is committed to creating unique, first-in-class drugs and is particularly recognized for its pioneering work in the field of immuno-oncology. The company's portfolio consists of prescription pharmaceuticals aimed at treating a range of diseases and conditions.

Recent filings

Filing Released Lang Actions
四半期報告書-第73期第1四半期(令和2年4月1日-令和2年6月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a Japanese 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act. It contains detailed financial statements, management analysis (MDA), and business updates for the first quarter of the 73rd fiscal period (April 1, 2020, to June 30, 2020). As it is a comprehensive financial report for a period shorter than a full fiscal year containing substantive financial data, it is classified as an Interim/Quarterly Report. Q1 2020
2020-08-06 Japanese
有価証券報告書-第72期(平成31年4月1日-令和2年3月31日)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. It contains the header information for the fiscal year ending March 31, 2020, and includes XBRL tagging data typical of a comprehensive annual financial filing. It is not an announcement or a summary, but the full regulatory annual report. FY 2020
2020-06-19 Japanese
四半期報告書-第72期第3四半期(令和1年10月1日-令和1年12月31日)
Interim / Quarterly Report Classification · 100% confidence The document is a Japanese 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act. It contains detailed financial statements, management analysis (MDA), and business updates for the third quarter of the 72nd fiscal period. It is a comprehensive financial report, not an announcement or a summary, and therefore qualifies as an Interim/Quarterly Report (IR). 9M 2020
2020-02-07 Japanese
四半期報告書-第72期第2四半期(2019/07/01-2019/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a '四半期報告書' (Quarterly Report) filed with the Kanto Local Finance Bureau in Japan. It contains detailed financial statements, management analysis (MDA), and business updates for the second quarter of the 72nd fiscal period (July 1, 2019, to September 30, 2019). It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q2 2020
2019-11-07 Japanese
四半期報告書-第72期第1四半期(2019/04/01-2019/06/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau in Japan, covering the first quarter of the 72nd fiscal period (April 1, 2019, to June 30, 2019). It contains detailed financial statements, management analysis (MDA), and operational updates, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2020
2019-08-07 Japanese
有価証券報告書-第71期(平成30年4月1日-平成31年3月31日)
Annual Report
2019-06-21 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.